Navigation Links
New research on sexual function
Date:8/19/2008

LINTHICUM, MD, August 18, 2008Young researchers presented innovative, early-stage research at the 16th Annual Summer Research Conference, a collaborative project of the AUA Foundation and the Society for Basic Urologic Research (SBUR), on August 7-9, 2008. The AUA Foundation hosted the forum for young investigators to showcase and discuss the most cutting-edge research in sexual medicine. These investigators represent the future of sexual medicine research and their contributions to the field will likely change how sexual dysfunction will be diagnosed and treated in the future.

The following notable findings were presented at the conference:

Metabolic syndrome can impact erectile function. Researchers tested the theory that statins might improve sexual function in men with metabolic syndrome. Researchers injected statins three times a day into 16-20 week old rats for five days. The statins alleviated vascular constriction associated with metabolic syndrome and improved erectile function.

Reversal of Voltage-Dependent Erectile Responses in the Obese-Zucker Rat by Statins was Mediated by Alteration in Rho/ Rho‐kinase Signaling
Christopher Wingard, PhD

Convention dictates depriving hypogonadal men of testosterone after a radical prostatectomy to avoid the possibility of feeding any remaining cancerous cells. However, researchers argue that androgen therapy may actually restore sexual function faster post-prostatectomy than androgen deprivation with (PDE ) 5 inhibitors. New studies are underway to test this theory.

Androgens and Sexual Function.
Mohit Khera, MD, MBA

While most studies group diabetic subjects into one cohort, Chitaley's study separated mice into type I and type II diabetes categories. Separating diabetic mice into separate cohorts showed that unique dysfunctions are at the root of erectile dysfunction in type I vs. type II diabetic mice. Future treatment of diabetes-related erectile dysfunction may differ depending on which type of diabetes is present.

Type I and Type II Diabetic-Erectile Dysfunction: Same Diagnosis (ICD-9), Different Disease?
Kanchan Chitaley, PhD


'/>"/>

Contact: Lacey Holt
lholt@AUAnet.org
401-689-4054
American Urological Association
Source:Eurekalert

Related medicine news :

1. Make an Impact on Pediatric Cancer Research Before Summers End: Try Some Virtual Lemonade!
2. New method to overcome multiple drug resistant diseases developed by Stanford researchers
3. Medco Announces Research Collaboration with FDA Focused on Personalized Medicine
4. SAGE to publish Journal of Dental Research beginning in 2009
5. Dunkin Donuts Event Raises $800,000 for Cancer Research in One Day
6. Researchers Examine Safety of Internet Prescriber Service Providing Erectile Dysfunction Medications
7. Researchers examine safety of Internet prescriber service providing erectile dysfunction medications
8. Tiny molecule helps control blood-vessel development, UT Southwestern researchers find
9. ABC Releases Monograph on Scientific Research of POM Wonderful(R) Pomegranate Juice
10. Morris Animal Foundation Receives $1 Million Donation From Hills for Cat Health Research - Cat Lovers Have Reason to Celebrate
11. DIA Innovation Forum to Highlight Latest Initiatives in Research & Development in the EU
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy ... health literacy software tool, and the Cancer Patient Education Network (CPEN), an independent ... today announce a new strategic alliance. , As CPEN’s strategic partner, HLI ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... CHICAGO , Sept. 28, 2017 Hill-Rom ... quarter 2017 earnings conference call and webcast on Friday, ... 8:00 a.m. (EDT) and ending at approximately 8:30 a.m. ... to discussing the company,s 2017 financial performance and guidance ... growth opportunities, initiatives to enhance operational performance, and long-range ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
Breaking Medicine Technology: